相关实验视频

Updated: Sep 20, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

塞米普利马布用于转移性基底细胞癌的治疗

Monika Bapna¹, Emily Ruiz²

¹Department of Dermatology, Georgetown University School of Medicine, Washington, DC, USA.

Future oncology (London, England)

|May 28, 2025

概括

塞米普利马布为那些不能忍受或没有对先前疗法的反应的患者提供了转移性基底细胞癌 (mBCC) 的新疗法. 这种PD-1抑制剂提供了持久的疾病控制与良好的安全性,提高生活质量.

科学领域:

在瘤学瘤学.
皮肤病学皮肤病学
免疫治疗是一种免疫疗法.

背景情况:

转移性基底细胞癌 (mBCC) 是一种罕见的,具有有限治疗选择的侵袭性皮肤癌.
刺途径抑制剂 (HHIs) 在mBCC.中显示出适度的疗效,但长期耐受性较差.
对于患有晚期mBCC的患者,需要新的治疗策略.

研究的目的:

审查CPD-1抑制剂塞米普利马布在治疗mBCC.的作用.
评估塞米普利马布的疗效,安全性和现实世界的性能.
为了比较塞米普利马布与现有的治疗方法,如HHI.

主要方法:

关于PubMed和临床试验注册的综合文献综述.
评估塞米普利马布的药理概况,临床试验数据和现实世界的证据.
对mBCC患者治疗结果,安全性和生活质量的分析.

主要成果:

塞米普利马布是对mBCC患者的转化疗法,mBCC患者进展或不耐受HHI.
它证明了有意义和持久的疾病控制.
塞米普利马布提供了有利的安全性,并保持了生活质量,尽管反应率低于皮肤状细胞癌.

结论:

塞米普利马布代表了mBCC治疗的重大进步.
它为那些选择有限的患者提供了一个有价值的选择.
未来的研究可能会通过生物标志物,新辅助策略和组合疗法来优化其使用.

关键词:

转移性基底细胞癌 (mBCC)这是一种PD-1抑制剂.晚期的基底细胞癌瘤.在Cemiplimab,我们可以看到.在瘤学中使用检查点抑制剂.刺抑制剂的耐药性刺抑制剂的耐力免疫治疗皮肤癌的免疫疗法在免疫疗法中的真实世界的证据.

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...